FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of psychoneurology, in particular to medications for treatment of disseminated sclerosis, representing 1,3-dialkylbenzimidazolium halogenides of general formula
EFFECT: medications ensure high treatment efficiency.
1 tbl, 3 ex
Authors
Dates
2011-05-20—Published
2010-04-08—Filed